Abstract
Tick-borne encephalitis (TBE) is a neuroviral disease that ranges in severity from a mild febrile illness to a severe and life-threatening meningoencephalitis or encephalomyelitis. There is increasing evidence that susceptibility to tick-borne encephalitis virus (TBEV)-induced disease and its severity are largely influenced by host genetic factors, in addition to other virus- and host-related factors. In this study, we investigated the contribution of selected single nucleotide polymorphisms (SNPs) in innate immunity genes to predisposition to TBE in humans. More specifically, we investigated a possible association between SNPs rs304478 and rs303212 in the gene Interferon Induced Protein With Tetratricopeptide Repeats 1 (IFIT1), rs7070001 and rs4934470 in the gene Interferon Induced Protein With Tetratricopeptide Repeats 2 (IFIT2), and RIG-I (Retinoic acid-inducible gene I) encoding gene DDX58 rs311795343, rs10813831, rs17217280 and rs3739674 SNPs with predisposition to TBE in population of the Czech Republic, where TBEV is highly endemic. Genotypic and allelic frequencies for these SNPs were analyzed in 247 nonimmunized TBE patients and compared with 204 control subjects. The analysis showed an association of IFIT1 rs304478 SNP and DDX58 rs3739674 and rs17217280 SNPs with predisposition to TBE in the Czech population indicating novel risk factors for clinical TBE but not for disease severity. These results also highlight the role of innate immunity genes in TBE pathogenesis.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Tick-borne encephalitis (TBE), a neuroviral disease transmitted by ticks, is common in much of the forested areas of Europe and Asia (Mansfield et al. 2009; Ruzek et al. 2019). More than 10,000 clinical cases of TBE are reported each year, although effective vaccines against TBE are available (Mansfield et al. 2009; Ruzek et al. 2019). TBE is caused by the tick-borne encephalitis virus (TBEV; Orthoflavivirus encephalitidis), which belongs to the Flaviviridae family and the Orthoflavivirus genus (Zerbini et al. 2023). The clinical presentation of TBE varies from a mild febrile illness to severe and life-threatening meningoencephalitis or encephalomyelitis (Bogovic and Strle 2015). In addition, a significant proportion of TBE infections are thought to be asymptomatic (Bojkiewicz et al. 2022; Gritsun et al. 2003). However, what determines the predisposition to TBEV-mediated disease and the severity of TBE remains poorly understood, but it is thought that both viral and host factors play important roles. Viral factors include the virulence hypothesis, which states that some TBEV strains are more virulent than others and lead to more severe disease (Leonova et al. 2013, 2014). Age and immune status are among the most important host factors determining the severity of TBE, as older individuals are more susceptible to more severe forms of TBE with higher mortality rates than younger individuals (Jelenik et al. 2010). There is increasing evidence that host genetic factors also play a critical role in determining predisposition to clinically manifest TBE and to varying degrees of severity of infection (Barkhash et al. 2016, 2018a, b; 2012, 2010, 2013; Czupryna et al. 2017; Kindberg et al. 2008; Mickienė et al. 2014).
Animal models of TBE have identified several candidate genes that influence survival after TBEV infection, including Oas1b, Cd33, Klk1b22, Siglece, Klk1b16, Fut2, Grwd1, Abcc6, Otog, and Mkrn3 (Palus et al. 2018, 2013). The predisposition to TBE in humans has been studied in detail, especially in the Russian population. Specifically, candidate gene analyses demonstrated that single nucleotide polymorphisms (SNPs) in the OAS2, OAS3, CD209, TLR3, IL28B, MMP9, and IL10 genes, which encode key components of the innate immune response, are associated with predisposition to TBE in Russian residents from Novosibirsk and Irkutsk (Barkhash et al. 2016, 2018a, b; 2012, 2010, 2013). Also, a functional Toll-like receptor 3 gene (TLR3) and nonfunctional CCR5Δ32 mutation were found to be risk factors for TBE (Kindberg et al. 2008; Mickienė et al. 2014). However, our recent work shows that genetic determinants may differ greatly between different populations, as the role of the MMP9 SNP in TBE predisposition clearly demonstrated in Russian residents was not observed in Czech TBE patients (Fortova et al. 2023). This highlights the importance of studying genetic markers of TBE predisposition in different populations living in TBE endemic areas.
The Czech Republic (population 10.5 million) is among the countries with the highest TBE incidence in Europe outside Russia. Since the early 1990s, there has been a steep increase in reported TBE cases in the Czech Republic, and this situation continues to this day, with some annual fluctuations (Kriz et al. 2012). The previous peak of cases reported per year was 1029 cases in 2006, and in the last 10 years the number of cases has fluctuated between 355 (2015) and 855 (2020) with a median of 628 cases per year. The genetic factors determining the predisposition to TBE in the Czech population are largely unknown. The aim of this study was to investigate a possible association between polymorphisms in key innate immunity genes and susceptibility to TBEV-mediated diseases in the Czech population.
Interferon (IFN) secretion from virus-infected cells is a key feature of the host’s antiviral immune response (Zhou et al. 2013). In TBE patients, several IFNs were found to be up-regulated. Notably, there was a trend toward higher expression of IFNβ and IFNλ3 in patients with a milder clinical presentation of the disease (Grygorczuk et al. 2015). Conversely, the highest levels of IFNγ in the cerebrospinal fluid were observed in patients with severe TBE presenting with disorders of consciousness (Kondrusik et al. 2005). IFNs exert their antiviral effects through inducing antiviral proteins. Hundreds of IFN-stimulated genes include the IFITs (IFN-induced protein with tetratricopeptide repeats) family (Zhou et al. 2013).
Here, we examined selected SNPs in the genes IFIT1, IFIT2, and RIG-I (Retinoic acid-inducible gene I) encoding gene DDX58. The IFIT1 and IFIT2 genes encode IFIT1 and IFIT2, respectively, and both are located on chromosome 10 (Zhou et al. 2013). The IFIT1 protein specifically binds single-stranded RNA carrying a 5' triphosphate group, acting as a sensor for viral single-stranded RNAs and inhibiting the expression of viral messenger RNAs. The IFIT2 protein inhibits the expression of viral messenger RNAs lacking 2'-O-methylation of the 5'-cap and may promote apoptosis (Zhou et al. 2013). The Retinoic Acid-inducible Gene I (RIG-I) protein, a member of RIG-I-like receptor family, is encoded by DDX58 gene and is involved in the recognition of viral double-stranded RNA and in the regulation of the antiviral innate immune response (Brisse and Ly 2019).
Because the severity and outcome of TBEV infection depend particularly on the efficiency of innate and adaptive immunity in suppressing viral replication, we hypothesized that polymorphisms in the human IFIT1, IFIT2, and DDX58 genes might have major effects on the outcome of TBEV infection.
Patients and methods
Patients and blood sampling
Blood samples were obtained from 247 patients (aged 3–87 years, mean 47.98 years), who were divided into two subgroups: Patients with meningitis (TBE-mening; n = 129, 64 male, aged 3–87 years, mean 44.46 years) and patients with more severe forms of TBE (encephalitis, meningoencephalitis, encephalomyelitis; TBE-enc; n = 118, 69 male, aged 18–84 years, mean 51.51 years). TBE diagnosis was made according to the case definition and based on the following criteria: (i) the presence of clinical signs of meningitis, meningoencephalitis, or meningoencephalomyelitis and epidemiologic association; (ii) CSF pleocytosis (> 5 cells/µl); and (iii) the presence of TBEV-specific IgM and IgG antibodies in serum or TBE-specific IgM antibodies in CSF. None of the patients had been vaccinated against TBE. Blood samples from 204 blood donors (161 male) living in the same area as the patients served as negative controls. Males and females in control group were distinguished based on sex determining region Y (SRY) located in the short arm of human chromosome Y using gb Genetic Sry kit (Generi Biotech, Hradec Kralove, Czech Republic). Total amount of genomic DNA in reaction mixture was in a range of 4–400 ng. The protocol of qPCR was set up according to manufacturer’s instructions. All patients and blood donors lived in the South Moravia region, Czech Republic.
SNP genotyping
Genomic DNA was extracted from whole blood using the QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions. The TaqMan® SNP Genotyping Assay (ThermoFisher Scientific, Waltham, MA, USA) was used to genotype SNPs rs304478, rs303212 polymorphism in the IFIT1 gene, rs7070001, rs4934470 polymorphism in the IFIT2 gene, and rs11795343, rs10813831, rs17217280, and rs3739674 polymorphism in the DDX58 gene (Table 1). Amplification mixes contained 10 ng of DNA, 1xTaqMan® Genotyping Master Mix (ThermoFisher Scientific, Waltham, MA, USA), 1xTaqMan® SNP Genotyping Assay (ThermoFisher Scientific, Waltham, MA, USA) including allele-specific probe and primers labelled with the two allele-specific fluorescent reporter dyes VIC and FAM, and Milli-Q water in a 10 µl reaction. PCR reactions were performed using the LightCycler® 480 System (Roche, Hague Rd., Indianapolis, USA) in 96-well plates. The PCR profile was as follows: 10 min at 95 °C and 40 cycles of 15 s at 95 °C followed by 60 s at 60 °C. There were two negative controls on each plate. Post-read allele discrimination analysis was performed after amplification.
Statistical analyses
Genotypic and allelic SNP frequencies were compared between the studied TBE patient and control groups with the χ2 test using GraphPad Prism 9 version 9.3.0 (GraphPad Software, La Jolla, CA, USA). The difference between two groups was considered significant if the p-value was less than 0.05.
Results and discussion
IFNs play a key role in restriction of TBEV infection, but their antiviral activities are exerted via activation of antiviral proteins rather than directly. Among hundreds of IFN-stimulated genes, IFITs play a central role in the antiviral response. The human IFIT gene family generally consists of four members (IFIT1, IFIT2, IFIT3, and IFIT5) (Zhou et al. 2013). IFIT1 and IFIT2 are among the proteins that are readily activated after TBEV infection (Selinger et al. 2022). Pattern recognition receptors such as RIG-I, which in humans is encoded by the gene DDX58, play a key role in IFN production following TBEV infection (Miorin et al. 2012). Therefore, we focused our attention on these major players in the innate immune response to TBEV infection and performed an analysis of genotypic and allelic frequencies of polymorphisms in selected SNPs in the human IFIT1, IFIT2, and DDX58 genes that may have major implications for the outcome of TBEV infection.
The genotypic and allelic frequencies of SNPs rs304478 and rs303212 for the IFIT1 gene, rs7070001 and rs4934470 for the IFIT2 gene, and rs311795343, rs10813831, rs17217280, and rs3739674 for the DDX58 gene in TBE patients are shown in Table 2. The group of TBE patients included the subgroups of TBE-mening and TBE-enc. Frequencies were compared between the total number of TBE patients and the control group, and between TBE-enc patients and either TBE-mening patients or the control group.
For the IFIT1 rs304478 SNP, significant differences in the frequency of G/G homozygotes were found between all TBE patients (28.9%) and the control group (49.4%) (P < 0.001). A significant difference (P = 0.001) was found between the TBE-enc patients (47.5%) and the control group. In addition, the frequency of G/T heterozygotes was significantly higher in the control group (47.6%) than in TBE patients (22.3%) or in TBE-enc patients (22.0%) (P < 0.001). In addition, the frequency of the G allele for this SNP is significantly lower in the control group (52.7%) compared with all TBE patients (60.5%) (P = 0.018). Similarly, the rs304478 SNP has been found previously to be associated with a sustained virological response in hepatitis C infection (Lopez-Rodriguez et al. 2011). No statistically significant differences, however, were observed in genotype and/or allele frequencies in IFIT1 rs303212 SNP.
For IFIT2, no statistically significant differences were found between the compared groups in genotype or allele frequencies for SNPs rs707001 and rs4934470.
For the DDX58 gene SNP rs3739674, in TBE patients (71.6%), including TBE-enc (71.24%), a significant increase in the frequency of C/C homozygotes was found compared with the control group (55.4%) (P < 0.001 and 0.005). For the same SNP, the frequency of G/C heterozygotes is significantly lower in TBE patients (14.6%), especially in TBE-enc patients (13.5%) compared with the control group (29.9%) (P < 0.001 and P = 0.001, respectively). In addition, a significant increase in C allele frequency for this SNP was detected in TBE patients (78.9%) and TBE-enc patients (78.0%) compared with the control group (70.3%) (P = 0.003 and 0.035, respectively). Previous studies reported an association of DDX58 rs3739674 polymorphism with an increased risk of enterovirus 71-associated hand, foot, and mouth disease in Chinese children and with the disease severity (Li et al. 2018, 2022).
For the DDX58 gene SNP rs17217280, a significant increase in T/T homozygotes was observed only in the control group (4.4%) compared with all TBE patients (0%) (P = 0.001) and with TBE-enc patients (P = 0.021). For the same SNP, significant differences in the frequencies of T/A heterozygotes were observed between TBE patients (27.1%) and the control group (18.6%) (P = 0.034).
Taken together, this study found that SNPs in the IFIT1 and DDX58 genes are associated with predisposition to TBE in the Czech population representing new risk factors for TBE. Our results provide further evidence for the importance of host genetic factors in predisposition to TBE and add new candidate genes to the list of previously identified genetic polymorphisms that may be involved in this process in humans. Our results also suggest that genes associated with innate immune response may have a major impact on overall susceptibility to clinically manifest TBEV infection. The significance of IFIT1, IFIT2, and RIG-I in flavivirus infections has been well-documented (Guo et al. 2018; Cho et al. 2013; Kimura et al. 2013). Nevertheless, this study is the first, to the best of our knowledge, to investigate the impact of specific SNPs within the genes encoding these proteins on susceptibility and/or the severity of flavivirus infections. Further research is required to explore the role of these SNPs in patients infected with other flaviviruses.
In addition, further validation studies in larger TBE cohorts from different populations are needed to verify our findings. Genome-wide association studies (GWAS) may also be useful to determine the involvement of these and other genes in the development of TBE. In any case, this study provides new insights into our understanding of TBE pathogenesis and TBEV-host interactions.
Data availability
The data supporting the results of this study are available from the corresponding author upon reasonable request.
References
Barkhash AV, Babenko VN, Voevoda MI, Romaschenko AG (2016) Association of IL28B and IL10 gene polymorphism with predisposition to tick-borne encephalitis in a Russian population. Ticks Tick Borne Dis 7:808–812
Barkhash AV, Kochneva GV, Chub EV, Romaschenko AG (2018a) Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian population. Microbes Infect 20:212–216
Barkhash AV, Perelygin AA, Babenko VN, Brinton MA, Voevoda MI (2012) Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis. Antiviral Res 93:64–68
Barkhash AV, Perelygin AA, Babenko VN, Myasnikova NG, Pilipenko PI, Romaschenko AG, Voevoda MI, Brinton MA (2010) Variability in the 2’-5’-oligoadenylate synthetase gene cluster is associated with human predisposition to tick-borne encephalitis virus-induced disease. J Infect Dis 202:1813–1818
Barkhash AV, Voevoda MI, Romaschenko AG (2013) Association of single nucleotide polymorphism rs3775291 in the coding region of the TLR3 gene with predisposition to tick-borne encephalitis in a Russian population. Antiviral Res 99:136–138
Barkhash AV, Yurchenko AA, Yudin NS, Ignatieva EV, Kozlova IV, Borishchuk IA, Pozdnyakova LL, Voevoda MI, Romaschenko AG (2018b) A matrix metalloproteinase 9 (MMP9) gene single nucleotide polymorphism is associated with predisposition to tick-borne encephalitis virus-induced severe central nervous system disease. Ticks Tick Borne Dis 9:763–767
Bogovic P, Strle F (2015) Tick-borne encephalitis: a review of epidemiology, clinical characteristics, and management. World J Clin Cases 3:430–441
Bojkiewicz E, Toczylowski K, Grygorczuk S, Zelazowska-Rutkowska B, Dunaj J, Zebrowska A, Czupryna P, Moniuszko-Malinowska A, Sulik A (2022) The prevalence of asymptomatic infections with tick-borne encephalitis virus and attitude towards tick-borne encephalitis vaccine in the endemic area of northeastern Poland. Vaccines (Basel) 10
Brisse M, Ly H (2019) Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5. Front Immunol 10:1586
Cho H, Shrestha B, Sen GC, Diamond MS (2013) A role for Ifit2 in restricting West Nile virus infection in the brain. J Virol 87:8363–8371
Czupryna P, Parczewski M, Grygorczuk S, Pancewicz S, Zajkowska J, Dunaj J, Kondrusik M, Krawczuk K, Moniuszko-Malinowska A (2017) Analysis of the relationship between single nucleotide polymorphism of the CD209, IL-10, IL-28 and CCR5 D32 genes with the human predisposition to developing tick-borne encephalitis. Postepy Hig Med Dosw (online) 71:788–796
Fortova A, Hönig V, Salat J, Palus M, Pychova M, Krbkova L, Barkhash AV, Kriha MF, Chrdle A, Lipoldova M, Ruzek D (2023) Serum matrix metalloproteinase-9 (MMP-9) as a biomarker in paediatric and adult tick-borne encephalitis patients. Virus Res 324:199020
Gritsun TS, Nuttall PA, Gould EA (2003) Tick-borne flaviviruses. Adv Virus Res 61:317–371
Grygorczuk S, Parczewski M, Moniuszko A, Świerzbińska R, Kondrusik M, Zajkowska J, Czupryna P, Dunaj J, Boroń-Kaczmarska A, Pancewicz S (2015) Increased concentration of interferon lambda-3, interferon beta and interleukin-10 in the cerebrospinal fluid of patients with tick-borne encephalitis. Cytokine 71:125–131
Guo HY, Zhang XC, Jia RY (2018) Toll-like receptors and RIG-I-like receptors play important roles in resisting flavivirus. J Immunol Res 2018:6106582
Jelenik Z, Keller M, Briggs B, Günther G, Haglund M, Hudeckova H, Jilkova E, Mickiene A, Sandell B, Steffen R, Strle F (2010) Tick-borne encephalitis and golden agers: position paper of the International Scientific Working Group on Tick-borne encephalitis (ISW-TBE). Wien Med Wochenschr 160:247–251
Kimura T, Katoh H, Kayama H, Saiga H, Okuyama M, Okamoto T, Umemoto E, Matsuura Y, Yamamoto M, Takeda K (2013) Ifit1 inhibits Japanese encephalitis virus replication through binding to 5’ capped 2’-O unmethylated RNA. J Virol 87:9997–10003
Kindberg E, Mickiene A, Ax C, Akerlind B, Vene S, Lindquist L, Lundkvist A, Svensson L (2008) A deletion in the chemokine receptor 5 (CCR5) gene is associated with tickborne encephalitis. J Infect Dis 197:266–269
Kondrusik M, Zajkowska J, Pancewicz S, Swierzbińska R, Grygorczuk S, Hermanowska-Szpakowicz T (2005) Interferon gamma concentration in the cerebrospinal fluid of patients with tick-borne encephalitis. Neurol Neurochir Pol 39:109–113
Kriz B, Maly M, Benes C, Daniel M (2012) Epidemiology of tick-borne encephalitis in the Czech Republic 1970–2008. Vector Borne Zoonotic Dis 12:994–999
Leonova GN, Belikov SI, Kondratov IG, Takashima I (2013) Comprehensive assessment of the genetics and virulence of tick-borne encephalitis virus strains isolated from patients with inapparent and clinical forms of the infection in the Russian Far East. Virology 443:89–98
Leonova GN, Maystrovskaya OS, Kondratov IG, Takashima I, Belikov SI (2014) The nature of replication of tick-borne encephalitis virus strains isolated from residents of the Russian Far East with inapparent and clinical forms of infection. Virus Res 189:34–42
Li YP, Li M, Jia XL, Deng HL, Wang WJ, Wu FP, Wang J, Dang SS (2018) Association of gene polymorphisms of pattern-recognition receptor signaling pathway with the risk and severity of hand, foot, and mouth disease caused by enterovirus 71 in Chinese Han population. J Med Virol 90:692–698
Li YP, Liu CR, Deng HL, Wang MQ, Tian Y, Chen Y, Zhang YF, Dang SS, Zhai S (2022) DNA methylation and single-nucleotide polymorphisms in DDX58 are associated with hand, foot and mouth disease caused by enterovirus 71. PLoS Negl Trop Dis 16:e0010090
Lopez-Rodriguez R, Trapero-Marugan M, Borque MJ, Roman M, Hernandez-Bartolome A, Rodriguez-Muñoz Y, Martin-Vilchez S, Abad-Santos F, Muñoz de Rueda P, Vidal-Castiñeira JR, Rodrigo L, Salmeron J, Moreno-Otero R, Sanz-Cameno P (2011) Genetic variants of interferon-stimulated genes and IL-28B as host prognostic factors of response to combination treatment for chronic hepatitis C. Clin Pharmacol Ther 90:712–721
Mansfield KL, Johnson N, Phipps LP, Stephenson JR, Fooks AR, Solomon T (2009) Tick-borne encephalitis virus - a review of an emerging zoonosis. J Gen Virol 90:1781–1794
Mickienė A, Pakalnienė J, Nordgren J, Carlsson B, Hagbom M, Svensson L, Lindquist L (2014) Polymorphisms in chemokine receptor 5 and Toll-like receptor 3 genes are risk factors for clinical tick-borne encephalitis in the Lithuanian population. PLoS ONE 9:e106798
Miorin L, Albornoz A, Baba MM, D’Agaro P, Marcello A (2012) Formation of membrane-defined compartments by tick-borne encephalitis virus contributes to the early delay in interferon signaling. Virus Res 163:660–666
Palus M, Sohrabi Y, Broman KW, Strnad H, Šíma M, Růžek D, Volkova V, Slapničková M, Vojtíšková J, Mrázková L, Salát J, Lipoldová M (2018) A novel locus on mouse chromosome 7 that influences survival after infection with tick-borne encephalitis virus. BMC Neurosci 19:39
Palus M, Vojtíšková J, Salát J, Kopecký J, Grubhoffer L, Lipoldová M, Demant P, Růžek D (2013) Mice with different susceptibility to tick-borne encephalitis virus infection show selective neutralizing antibody response and inflammatory reaction in the central nervous system. J Neuroinflammation 10:77
Ruzek D, Avšič Županc T, Borde J, Chrdle A, Eyer L, Karganova G, Kholodilov I, Knap N, Kozlovskaya L, Matveev A, Miller AD, Osolodkin DI, Överby AK, Tikunova N, Tkachev S, Zajkowska J (2019) Tick-borne encephalitis in Europe and Russia: Review of pathogenesis, clinical features, therapy, and vaccines. Antiviral Res 164:23–51
Selinger M, Věchtová P, Tykalová H, Ošlejšková P, Rumlová M, Štěrba J, Grubhoffer L (2022) Integrative RNA profiling of TBEV-infected neurons and astrocytes reveals potential pathogenic effectors. Comput Struct Biotechnol J 20:2759–2777
Zerbini FM, Siddell SG, Lefkowitz EJ, Mushegian AR, Adriaenssens EM, Alfenas-Zerbini P, Dempsey DM, Dutilh BE, García ML, Hendrickson RC, Junglen S, Krupovic M, Kuhn JH, Lambert AJ, Łobocka M, Oksanen HM, Robertson DL, Rubino L, Sabanadzovic S, Simmonds P, Smith DB, Suzuki N, Van Doorslaer K, Vandamme AM, Varsani A (2023) Changes to virus taxonomy and the ICTV Statutes ratified by the International Committee on Taxonomy of Viruses (2023). Arch Virol 168:175
Zhou X, Michal JJ, Zhang L, Ding B, Lunney JK, Liu B, Jiang Z (2013) Interferon induced IFIT family genes in host antiviral defense. Int J Biol Sci 9:200–208
Funding
Open access publishing supported by the National Technical Library in Prague. The study was supported by the Czech Ministry of Health (grant No. NU22-05–00659) and the project National Institute of Virology and Bacteriology (Programme EXCELES, ID Project No. LX22N-PO5103)—Funded by the European Union—Next Generation EU.
Author information
Authors and Affiliations
Contributions
AVB and DR designed and conceived the study. AF, MPa, and JS performed the experiments and analyzed the data. MPi and LK collected the clinical material. DR wrote the initial manuscript draft. All authors reviewed and edited the paper and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethics approval and consent to participate
The study was performed according to the guidelines of the Declaration of Helsinki and approved by the Ethics Committee of the University Hospital in Brno (date of approval: June 27, 2018). All patients or their parents consented to participate in the study and signed an informed consent form.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fortova, A., Barkhash, A.V., Pychova, M. et al. Genetic polymorphisms in innate immunity genes influence predisposition to tick-borne encephalitis. J. Neurovirol. 29, 699–705 (2023). https://doi.org/10.1007/s13365-023-01182-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13365-023-01182-8